Innate immune responses in respiratory syncytial virus infections

Viral Immunology

Volumn 17, Issue 2, 2004, Pages 220-233

  Krishnan, Subramaniam ^a   Halonen, Marilyn ^a,b   Welliver Sr , Robert C ^c,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA INTERFERON; CHEMOKINE; CYTOKINE; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 11; INTERLEUKIN 8; LEUKOTRIENE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN; RANTES; SURFACTANT; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; CELL INTERACTION; DENDRITIC CELL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MEDIATOR RELEASE; NEUROIMMUNOLOGY; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW;

HUMANS; IMMUNITY, NATURAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES;

EID: 3042776066     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/0882824041310612     Document Type: Review

References (102)

1. Aberle, J.H., S.W. Aberle, M.N. Dworzak, et al. 1999. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 160:1263-1268.
2. Alam, R., M.A. Let-Brown, P.A. Forsythe, et al. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723-728.
3. Anderson, J.J., M. Serin, J. Harrop, et al. 1989. Natural killer cell response to respiratory syncytial virus in the BALB/c mouse model. Adv. Exp. Med. Biol. 257:211-220.
4. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
5. Barnes, P.J. 1986. Non-adrenergic non-cholinergic neural control of human airways. Arch. Int. Pharmacodyn 280:208-228.
6. Barr, F.E., H. Pedigo, T.R. Johnson, et al. 2000. Surfactant protein A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages. Am. J. Respir. Cell Mol. Biol. 23:586-592.
7. Becker, S., and J.M. Soukup. 1999. Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial virus infection. Immunobiology 201:88-106.
8. Becker, S., J. Quay and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147:4307-4312.
9. Behera, A.K., M. Kumar, H. Matsuse, et al. 1998. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem. Biophys. Res. Commun. 251:704-709.
10. Bendelja, K., A. Gagro, A. Bace, et al. 2000. Predominant type-2 response in infants with respiratory syncytial virus infection demonstrated by cytokine flow cytometry. Clin. Exp. Immunol. 121:332-338.
11. Biron, C.A., K.B. Nguyen, G.C. Pien, et al. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
12. Bitko, V., A. Velazquez, L. Yang, et al. 1997. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 232:369-378.
13. Bont, L., C.J. Heijnen, A. Kavelaars, et al. 2001. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J. Infect. Dis. 184:355-358.
14. Bramley, A.M., T.Z. Vitalis, B.R. Wiggs, et al. 1999. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur. Respir. J. 14:1061-1067.
15. Chini, B.A., M.A. Fiedler, L. Milligan, et al. 1998. Essential roles of NF-kappa B and C/EBP in the regulation of ICAM-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures. J. Virol. 72:1623-1626.
16. Chipps, B.E., W.F. Sullivan, and J.M. Portnoy. 1993. Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr. Infect. Dis. 12:653-658.
17. Collins, P.L., K. McIntosh, and R.M. Chanock. 1996. Respiratory syncytial virus, pp. 1313-1351. In: B.N. Fields, D.M. Knipe, and P.M. Howley (eds.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia.
18. Domachowske, J.B., K.D. Dyer, C.A. Bonville, et al. 1998. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis. 177:1458-1464.
19. Domachowske, J.B., K.D. Dyer, A.G. Adams, et al. 1998. Eosinophil cationic protein/RNase 2: another eosinophil ribonuclease with direct antiviral activity. Nucleic Acids Res. 26:3358-3363.
20. Elias, J.A., Z. Zhu, G. Chupp, et al. 1999. Airway remodeling in asthma. J. Clin. Invest. 104:1001-1006.
21. Englund, J.A., C.J. Sullivan, M.C. Jordan, et al. 1988. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 109:203-208.
22. Everard, M.L., G. Fox, A.F. Walls, et al. 1995. Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch. Dis. Child. 72:64-69.
23. Fiedler, M.A., K. Wernk-Dollries, and J.M. Stark. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:L865-L872.
24. Franke-Ullmann, G., C. Pfortner, P. Walter, et al. 1995. Alteration of pulmonary macrophage function by respiratory syncytial virus in vitro. J. Immunol. 154:268-280.
25. Garofalo, R.P., J. Patti, K.A. Hintz, et al. 2001. Macrophage inflammatory protein-1alpha (not T helper 2 cytokine) is associated with severe forms of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 184:393-399.
26. Garofalo, R.P., K.H. Hintz, V. Hill, et al. Production of interferon-gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J. Med Virol. (in press).
27. Garofalo, R., J.L. Kimpen, R.C. Welliver, et al. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:28-32.
28. Ghildyal, R., C. Hartley, A. Varrasso, et al. 1999. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J. Infect. Dis. 180:2009-2013.
29. Glezen, W.P., L.H. Taber, A.L. Frank, et al. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
30. Griese, M. 2002. Respiratory syncytial virus and pulmonary surfactant. Viral Immunol. 15:357-363.
31. Haeberle, H.A., W.A. Kuziel, H.J. Dieterich, et al. 2001. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J. Virol. 75:878-890.
32. Haeberle, H.A., R. Takizawa, A. Casola, et al. 2002. Respiratory syncytial virus-induced activation of NF-kappa B in the lung involves alveolar macrophages and TLR-4-dependent pathways. J. Infect. Dis. 186:1199-1206.
33. Hall, C.B., and C.A. McCarthy. 1995. Principles and practice of infectious diseases, pp. 1501-1518. In: G.L. Mandel, J.E. Bennett, and R. Dolin (eds.), Churchill-Livingston, New York.
34. Harrington, R.D., T.M. Hooton, R.C. Hackman, et al. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 165:987-993.
35. Haynes, L.M., D.D. Moore, E.A. Kurt-Jones, et al. 2001. Involvement of TLR-4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730-10737.
36. Hickling, T.P., R. Malhotra, H. Bright, et al. 2000. Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. Viral Immunol. 13:125-135.
37. Hickling, T.P., H. Bright, K. Wing, et al. 1999. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur. J. Immunol. 29:3478-3484.
38. Hoebee, B., L. Bont, E. Rietveld, et al. 2004. Influence of promoter variants of IL-10, IL-9 and TNF-alpha genes on respiratory syncytial virus bronchiolitis. J. Infect. Dis. 189:239-247.
39. Holt, P.G., and P.A. Stumbles. 2000. Characterization of dendritic cell populations in the respiratory tract. J. Aerosol Med. 13:361-367.
40. Hornsleth, A., B. Klug, M. Nir, et al. 1998. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr. Infect. Dis. 17:1114-1121.
41. Hu, C., K. Wedde-Beer, A. Auais, et al. 2002. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J. Physiol. Lung Cell Mol. Physiol. 28:L494-L502.
42. Huh, J.C., D.H. Strickland, F.L. Jahnsen, et al. 2003. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J. Exp. Med. 198:19-30.
43. Hull, J., K. Rowlands, E. Lockhart, et al. 2003. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J. Infect. Dis. 188:904-907.
44. Hull, J., A. Thomson, and D. Kwiatkowski. 2000. Association of respiratory syncytial virus bronchiolitis with the interleukin-8 gene region in UK families. Thorax 55:1023-1027.
45. Hull, J., H. Ackerman, K. Isles, et al. 2001. Unusual haplotypic structure of IL-8, a susceptibility locus for a common respiratory virus. Am. J. Hum. Genet. 69:413-419.
46. Hussell, T., A. Pennycook, and P.J. Openshaw. 2001. Inhibition of tumor necrosis factor reduces the severity of virus-specific ling immunopathology. Eur. J. Immunol. 31:2566-2573.
47. + T cell recruitment during respiratory syncytial virus infection. J. Gen. Virol. 79:2593-2601.
48. Hussell, T., and P.J. Openshaw. 2000. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J. Immunol. 165:7109-7115.
49. Johnson, T.R., S. Hong, L. Van Kaer, et al. 2002. NK T cells contribute to expansion of CD8 T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76:4294-4303.
50. Joshi, P., A. Kakakios, J. Jayasekera, et al. 1998. A comparison of IL-2 levels in nasopharyngeal and endotrachea aspirates of babies with respiratory syncytial virus bronchiolitis. J. Allergy Clin. Immunol. 102:618-620.
51. Kaltreider, H.B., S. Ichikawa, P.K. Byrd, et al. 1997. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma [Abstract]. Am. J. Respir. Cell Mol. Biol. 16:133-144.
52. Kao, Y.J., P.A. Piedra, G.L. Larsen, et al. 2001. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 163:532-539.
53. Kim, H.W., S.L. Leikin, J. Arrobio, et al. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:75-78.
54. Kim, H.W., J.G. Canchola, C.D. Brandt, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
55. King, K.A., C. Hu, M.M. Rodriguez, et al. 2001. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am. J. Respir. Cell Mol. Biol. 24:101-107.
56. Krishnan, S., M. Craven, R.C. Welliver, et al. 2003. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J. Infect. Dis. 188:433-439.
57. Kurt-Jones, E.A., L. Popva, L. Kwinn, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
58. Lahti, M., J. Lofgren, R. Martilla, et al. 2002. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr. Res. 51:696-699.
59. Lambrecht, B.N., I. Carro-Muino, K. Vermaelen, et al. 1999. Allergen-induced changes in the bone-marrow progenitor and airway dendritic cells in sensitized rats. Am. J. Respir. Cell Mol. Biol. 20:1165-1174.
60. Lambrecht, B.N., R.A. Peleman, G.R. Bullock, et al. 2000. Sensitization to inhaled antigen by intratracheal instillation of dendritic cells. Clin. Exp. Allergy 30:214-224.
61. Larsen, G.L., and G.N. Colasurdo. 1999. Neural control mechanisms within airways: disruption by respiratory syncytial virus. J. Pediatr. 135:S21-S27.
62. Law, B.J., X. Carbonell-Estrany, and E.A. Simoes. 2002. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir. Med. 96:S1-S7.
63. Levine, A.M., and J.A. Whitsett. 2001. Pulmonary collectins and innate host defense of the lung. Microbes Infect. 3:161-166.
64. Levine, A.M., J. Gwozdz, J. Stark, et al. 1999. Surfactant protein A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 103:1015-1021.
65. Lofgren, J., M. Ramet, M. Renko, et al. 2002. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J. Infect. Dis. 185:283-289.
66. Lukacs, N.W., K.K. Tekkanat, A. Berlin, et al. 2001. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 167:1060-1065.
67. Mastronarde, J.G., M.M. Monick, N. Mukaida, et al. 1998. Activator protein-1 is the preferred transcription factor for cooperative interaction with NF-kappa B in respiratory syncytial virus-induced IL-8 gene expression in airway epithelium. J. Infect. Dis. 177:1275-1281.
68. Merolla, R., N.A. Rebert, P.T. Tsiviste, et al. 1995. Respiratory syncytial virus replication in human lung epithelial cells: inhibition by tumor necrosis factor alpha and interferon beta. Am. J. Respir. Crit. Care Med. 152:1358-1366.
69. Midulla, F., A. Villani, J.R. Panuska, et al. 1993. Respiratory syncytial virus lung infections in infants: immunoregulatory role of infected alveolar macrophages. J. Infect. Dis. 168:1515-1519.
70. Monick, M.M., T.O. Yarovinsky, L.S. Power, et al. 2003. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem. 278:53035-53044.
71. Morris, J.A., R.E. Blount, and R.E. Savage. 1956. Recovery of cytopathogenic agent from chimpanzee with coryza. Proc. Soc. Exp. Biol. Med. 92:544-594.
72. Neuzil, K.M., Y. Tang, and B.S. Graham. 1996. Protective role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo. Am. J. Med. Sci. 311:201-204.
73. Noah, T.L., and S. Becker. 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265:L472-L478.
74. Noah, T.L., F.W. Henderson, I.A. Wortman, et al. 1995. Nasal cytokine production in viral acute upper respiratory infection in childhood. J. Infect. Dis. 171:584-592.
75. Olszewska-Pazdrak, B., A. Casola, T. Saito, et al. 1998. Cell-specific expression of RANTES, MCP-1 and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72:4756-4764.
76. 2. Am. J. Physiol. 259:L396-L402.
77. Patel, N.R., J. Hammer, S. Nichani, et al. 1999. Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis. Intensive Care Med. 25:81-97.
78. Piedimonte, G. 1995. Tachykinin peptides, receptors and peptidases in airway disease. Exp. Lung Res. 21:809-834.
79. Piedimonte, G., M.M. Rodriguez, K.A. King, et al. 1999. Respiratory syncytial virus upregulates expression of substance P receptor in rat lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 277:L831-L840.
80. Piedimonte, G. 2003. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 22:S66-S75.
81. Renz, H. 2001. Neutrophins in bronchial asthma. Respir. Res. 2:265-268.
82. Said, S.I. 1998. Antiinflammatory actions of VIP in the lungs and airways, pp. 345-362. In: S.I. Said (ed.), Proinflammatory and Anti-Inflammatory Pepetides. Vol. 112. Dekker, New York.
83. Sheeran, P., H. Jafri, C. Carubelli, et al. 1999. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus. Pediatr. Infect. Dis. J. 18:115-122.
84. Skoner, D.P., P. Fireman, L. Caliguiri, et al. 1990. Plasma elevations of histamine and a prostaglandin metabolite in acute bronchiolitis. Am. Rev. Respir. Dis. 142:359-364.
85. Smyth, R.L., K.J. Mobbs, U. O'Hea, et al. 2002. Respiratory syncytial virus bronchiolitis: disease severity, interleukin-8 and virus genotype. Pediatr. Pulmonol. 33:339-346.
86. Soukup, J.M., and S. Becker. 2003. Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro. Clin. Immunol. 107:178-185.
87. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
88. Thomas, L.H., J.S. Friedland, M. Sharland, et al. 1998. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on NF-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J. Immunol. 161:1007-1016.
89. Trepicchio, W.L., L. Wang, M. Bozza, et al. 1997. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappa B. J. Immuol. 159:5661-5670.
90. Tsutsumi, H., R. Takeuchi, M. Ohsaki, et al. 1999. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression. J. Leukoc Biol. 66:99-104.
91. van Schaik, S.M., D.A. Tristram, I.S. Nagpal, et al. 1999. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J. Allery of Clin. Immunol. 103:630-636.
92. van Schaik, S.M., N. Obut, G. Enhorning, et al. 2000. Role of interferon-gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62:257-266.
93. Volovitz, B., R.C. Welliver, G. DeCastro, et al. 1988. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24:504-507.
94. Wang, S.-Z., H. Xu, A. Wraith, et al. 1998. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur. Respir. J. 12:612-618.
95. Wang, S., and K.D. Forsyth. 2000. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 5:1-9.
96. Wedde-Beer, K., C. Hu, M.M. Rodriguez, et al. 2002. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L1143-L1150.
97. Welliver, R.C., D.T. Wong, M. Sun, et al. 1981. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med. 305:841-845.
98. Welliver, R.C., R.P. Garofalo, and P.L. Ogra. 2002. Beta-chemokines, but neither T helper type 1 not T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 21:457-461.
99. Welliver, R.C., II, K.H. Hintz, M. Glori, et al. 2003. Zileuton reduces respiratory illness and lung inflammation, in respiratory syncytial virus infection, in mice. J. Infect. Dis. 187:1773-1779.
100. Whimbey, E., R.E. Champlin, J.A. Englund, et al. 1995. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 16:393-399.
101. Zelaya, C., E.A. Orvell, and O. Strannegard. 1994. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr. Allergy Immunol. 5:100-106.
102. Zhang, Y., B.A. Luxon, A. Casola, et al. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75:9044-9058.